Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Parathyroid Carcinoma—Setting the Stage for Prognosis

Authors: Winifred M. Lo, MD, Dhaval T. Patel, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

Parathyroid carcinoma is a rare disease with an increasing incidence,1 but without a staging system. In the development of a staging system, prognostic factors associated with overall survival include age at diagnosis, sex, nodal status, and primary tumor;2,3 however, the significance of these individual factors has been debated in prior studies, with a lack of consensus for inclusion in a staging system. The aim of our study4 was to determine whether the incidence continues to increase, and evaluate the prognostic factors associated with cancer-specific survival in patients with parathyroid carcinoma. …
Literature
1.
Lee PK, Jarosek SL, Virnig BA et al. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109(9):1736–41.CrossRefPubMed
2.
Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012;13(1):11–23.CrossRefPubMed
3.
Asare EA, Sturgeon C, Winchester DJ, et al. Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015;22(12):3990–5.CrossRefPubMed
4.
Lo WM, Good ML, Nilubol N, Perrier ND, and Patel DT. Tumor size and presence of metastatic disease at diagnosis are associated with disease-specific survival in parathyroid carcinoma. Ann Surg Oncol. 2018;25:2535–2540.CrossRefPubMed
5.
Harari A, Waring A, Fernandez-Ranvier G, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679–86.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Parathyroid Carcinoma—Setting the Stage for Prognosis
Authors
Winifred M. Lo, MD
Dhaval T. Patel, MD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6879-6

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue

ASO Author Reflections

ASO Author Reflections: Predicting High-Risk Oncotype DX Recurrence Scores as a Strategy for Assessing Neoadjuvant Chemotherapy Eligibility

ASO Author Reflections

ASO Author Reflections: Decision Timing for Organ Preservation in Rectal Cancer After Chemoradiation

ASO Author Reflections

ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective

ASO Author Reflections

ASO Author Reflections: Narrow-Band Imaging: A Novel Imaging Method in Minimally Invasive Surgery

Correction

Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations

ASO Author Reflections

ASO Author Reflections: Survival Impacts of Therapy and Complications in Gastric Adenocarcinoma